Alcon (ALC) Competitors $79.82 +0.38 (+0.47%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$79.48 -0.33 (-0.41%) As of 08/29/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALC vs. DXCM, HCA, THC, EHC, UHS, ENSG, ACHC, BKD, SEM, and USPHShould you be buying Alcon stock or one of its competitors? The main competitors of Alcon include DexCom (DXCM), HCA Healthcare (HCA), Tenet Healthcare (THC), Encompass Health (EHC), Universal Health Services (UHS), The Ensign Group (ENSG), Acadia Healthcare (ACHC), Brookdale Senior Living (BKD), Select Medical (SEM), and U.S. Physical Therapy (USPH). These companies are all part of the "medical" sector. Alcon vs. Its Competitors DexCom HCA Healthcare Tenet Healthcare Encompass Health Universal Health Services The Ensign Group Acadia Healthcare Brookdale Senior Living Select Medical U.S. Physical Therapy Alcon (NYSE:ALC) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Which has stronger earnings & valuation, ALC or DXCM? Alcon has higher revenue and earnings than DexCom. Alcon is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlcon$9.91B3.97$1.02B$2.1537.12DexCom$4.03B7.33$576.20M$1.4452.32 Do analysts prefer ALC or DXCM? Alcon presently has a consensus price target of $96.06, indicating a potential upside of 20.35%. DexCom has a consensus price target of $99.89, indicating a potential upside of 32.59%. Given DexCom's stronger consensus rating and higher probable upside, analysts plainly believe DexCom is more favorable than Alcon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alcon 0 Sell rating(s) 6 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.69DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 Does the media prefer ALC or DXCM? In the previous week, DexCom had 24 more articles in the media than Alcon. MarketBeat recorded 32 mentions for DexCom and 8 mentions for Alcon. DexCom's average media sentiment score of 1.28 beat Alcon's score of 0.16 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral DexCom 23 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, ALC or DXCM? Alcon has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Is ALC or DXCM more profitable? DexCom has a net margin of 13.29% compared to Alcon's net margin of 10.70%. DexCom's return on equity of 30.41% beat Alcon's return on equity.Company Net Margins Return on Equity Return on Assets Alcon10.70% 6.92% 4.89% DexCom 13.29%30.41%10.08% Do institutionals and insiders have more ownership in ALC or DXCM? 53.9% of Alcon shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 1.5% of Alcon shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryDexCom beats Alcon on 13 of the 17 factors compared between the two stocks. Get Alcon News Delivered to You Automatically Sign up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALC vs. The Competition Export to ExcelMetricAlconMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$39.37B$7.16B$5.75B$21.35BDividend YieldN/A1.19%4.08%3.49%P/E Ratio37.1226.1883.2729.34Price / Sales3.9755.35535.3652.51Price / Cash14.3621.7237.4423.91Price / Book1.787.0910.555.36Net Income$1.02B$176.42M$3.27B$996.52M7 Day Performance-2.70%0.83%0.40%0.34%1 Month Performance-8.76%3.53%7.31%5.52%1 Year Performance-18.29%7.54%46.58%11.66% Alcon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALCAlcon3.3431 of 5 stars$79.82+0.5%$96.06+20.4%-18.3%$39.37B$9.91B37.1225,599Analyst ForecastDXCMDexCom4.9842 of 5 stars$80.82-0.2%$99.89+23.6%+8.7%$31.74B$4.03B56.1310,300Positive NewsHCAHCA Healthcare4.5713 of 5 stars$393.86-0.5%$398.58+1.2%+2.2%$92.61B$70.60B16.56316,000News CoveragePositive NewsAnalyst ForecastTHCTenet Healthcare4.7085 of 5 stars$171.35-0.4%$191.88+12.0%+11.0%$15.20B$20.67B10.9798,000News CoveragePositive NewsAnalyst ForecastEHCEncompass Health4.8373 of 5 stars$120.26-0.1%$134.00+11.4%+30.8%$12.13B$5.37B23.5340,000Positive NewsInsider TradeUHSUniversal Health Services4.9721 of 5 stars$177.58-0.5%$213.77+20.4%-23.7%$11.36B$15.83B9.3599,000News CoveragePositive NewsAnalyst ForecastENSGThe Ensign Group4.6489 of 5 stars$164.06-1.3%$171.00+4.2%+13.5%$9.59B$4.26B29.7739,300News CoveragePositive NewsACHCAcadia Healthcare4.6843 of 5 stars$21.13+0.7%$40.77+93.0%-72.0%$1.94B$3.23B13.9925,500BKDBrookdale Senior Living3.1751 of 5 stars$7.34+0.3%$7.80+6.3%+8.4%$1.71B$3.13B-6.9936,000Positive NewsSEMSelect Medical4.997 of 5 stars$12.92+1.6%$24.60+90.4%-63.9%$1.58B$5.19B12.1944,100Positive NewsUSPHU.S. Physical Therapy3.8577 of 5 stars$84.53-1.5%$110.25+30.4%-3.2%$1.30B$671.34M36.917,028Positive News Related Companies and Tools Related Companies DexCom Competitors HCA Healthcare Competitors Tenet Healthcare Competitors Encompass Health Competitors Universal Health Services Competitors The Ensign Group Competitors Acadia Healthcare Competitors Brookdale Senior Living Competitors Select Medical Competitors U.S. Physical Therapy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALC) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alcon Please log in to your account or sign up in order to add this asset to your watchlist. Share Alcon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALC Stock Alerts